Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 348 articles:
HTML format
Text format



Single Articles


    January 2017
  1. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Text format     Abstract available


  2. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    PubMed     Text format     Abstract available


  3. YAO L, Chen W, Song K, Han C, et al
    15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    PLoS One. 2017;12:e0176106.
    PubMed     Text format     Abstract available


  4. LYTLE KA, Wong CP, Jump DB
    Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    PLoS One. 2017;12:e0173376.
    PubMed     Text format     Abstract available


  5. HE J, Yi B, Chen Y, Huang Q, et al
    The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
    PLoS One. 2017;12:e0175443.
    PubMed     Text format     Abstract available


  6. ALVA A, Cangalaya C, Quiliano M, Krebs C, et al
    Mathematical algorithm for the automatic recognition of intestinal parasites.
    PLoS One. 2017;12:e0175646.
    PubMed     Text format     Abstract available


  7. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    PubMed     Text format     Abstract available


  8. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Text format     Abstract available


  9. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Text format     Abstract available


  10. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available


  11. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Text format     Abstract available


  12. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    PubMed     Text format     Abstract available


  13. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    PubMed     Text format     Abstract available


    January 2016
  14. ISHIKAWA T, Abe S, Hoshii A, Yamada Y, et al
    Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    PLoS One. 2016;11:e0145546.
    PubMed     Text format     Abstract available


  15. THOMSEN KL, Macnaughtan J, Tritto G, Mookerjee RP, et al
    Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy.
    PLoS One. 2016;11:e0146076.
    PubMed     Text format     Abstract available


  16. POGGIOGALLE E, Lubrano C, Gnessi L, Mariani S, et al
    Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.
    PLoS One. 2016;11:e0145811.
    PubMed     Text format     Abstract available


  17. LV H, Zhang Z, Wu X, Wang Y, et al
    Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
    PLoS One. 2016;11:e0145195.
    PubMed     Text format     Abstract available


  18. YANO S, Takehara K, Miwa S, Kishimoto H, et al
    Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.
    PLoS One. 2016;11:e0148760.
    PubMed     Text format     Abstract available


  19. ZHANG B, Liang L, Dong Y, Lian Z, et al
    Intravoxel Incoherent Motion MR Imaging for Staging of Hepatic Fibrosis.
    PLoS One. 2016;11:e0147789.
    PubMed     Text format     Abstract available


  20. LI TH, Huang CC, Yang YY, Lee KC, et al
    Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats.
    PLoS One. 2016;11:e0147212.
    PubMed     Text format     Abstract available


  21. LU S, Natarajan SK, Mott JL, Kharbanda KK, et al
    Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway.
    PLoS One. 2016;11:e0147474.
    PubMed     Text format     Abstract available


  22. SANTOS-LOPEZ JA, Garcimartin A, Merino P, Lopez-Oliva ME, et al
    Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
    PLoS One. 2016;11:e0147469.
    PubMed     Text format     Abstract available


  23. KIM TY, Song do S, Kim HY, Sinn DH, et al
    Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition.
    PLoS One. 2016;11:e0146745.
    PubMed     Text format     Abstract available


  24. URASAKI Y, Pizzorno G, Le TT
    Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice.
    PLoS One. 2016;11:e0146994.
    PubMed     Text format     Abstract available


  25. LYTLE KA, Jump DB
    Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    PLoS One. 2016;11:e0146942.
    PubMed     Text format     Abstract available


  26. LEE EJ, Lee SJ, Kim JH, Kim KJ, et al
    Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic Cells.
    PLoS One. 2016;11:e0146463.
    PubMed     Text format     Abstract available


  27. WADA Y, Takami Y, Tateishi M, Ryu T, et al
    The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146456.
    PubMed     Text format     Abstract available


  28. MORO T, Nakao S, Sumiyoshi H, Ishii T, et al
    A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
    PLoS One. 2016;11:e0146592.
    PubMed     Text format     Abstract available


  29. PEREPELYUK M, Chin L, Cao X, van Oosten A, et al
    Normal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics.
    PLoS One. 2016;11:e0146588.
    PubMed     Text format     Abstract available


  30. CHEN Y, Wang W, Wang H, Li Y, et al
    Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.
    PLoS One. 2016;11:e0141159.
    PubMed     Text format     Abstract available


  31. HONDA Y, Imajo K, Kato T, Kessoku T, et al
    The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0146337.
    PubMed     Text format     Abstract available


  32. PARK JY, Murakami T, Lee JY, Zhang Y, et al
    Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
    PLoS One. 2016;11:e0146504.
    PubMed     Text format     Abstract available


  33. SHIBATA Y, Hara T, Nagano J, Nakamura N, et al
    The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
    PLoS One. 2016;11:e0146279.
    PubMed     Text format     Abstract available


  34. TAMADA H, Naito H, Kitamori K, Hayashi Y, et al
    Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.
    PLoS One. 2016;11:e0145939.
    PubMed     Text format     Abstract available


  35. FEIERSINGER F, Nolte E, Wach S, Rau TT, et al
    MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    PLoS One. 2016;11:e0148580.
    PubMed     Text format     Abstract available


  36. RAO Q, You A, Guo Z, Zuo B, et al
    Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
    PLoS One. 2016;11:e0148263.
    PubMed     Text format     Abstract available


  37. STACCHIOTTI A, Favero G, Lavazza A, Golic I, et al
    Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0148115.
    PubMed     Text format     Abstract available


  38. KUMAR S, Wang J, Rani R, Gandhi CR, et al
    Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice.
    PLoS One. 2016;11:e0147864.
    PubMed     Text format     Abstract available


  39. PIRHONEN J, Arola J, Sadevirta S, Luukkonen P, et al
    Continuous Grading of Early Fibrosis in NAFLD Using Label-Free Imaging: A Proof-of-Concept Study.
    PLoS One. 2016;11:e0147804.
    PubMed     Text format     Abstract available


  40. COOPER DA, Cordery DV, Zajdenverg R, Ruxrungtham K, et al
    Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naive HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial.
    PLoS One. 2016;11:e0144917.
    PubMed     Text format     Abstract available


  41. SREEKANTH GP, Chuncharunee A, Sirimontaporn A, Panaampon J, et al
    SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.
    PLoS One. 2016;11:e0149486.
    PubMed     Text format     Abstract available


  42. YAO L, Abe M, Kawasaki K, Akbar SM, et al
    Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0149948.
    PubMed     Text format     Abstract available


  43. JIANG Y, Li J, Wang J, Xiao H, et al
    Assessment of Vascularity in Hepatic Alveolar Echinococcosis: Comparison of Quantified Dual-Energy CT with Histopathologic Parameters.
    PLoS One. 2016;11:e0149440.
    PubMed     Text format     Abstract available


  44. GAO J, Ji JS, Ding XM, Ke S, et al
    Laparoscopic Radiofrequency Ablation for Large Subcapsular Hepatic Hemangiomas: Technical and Clinical Outcomes.
    PLoS One. 2016;11:e0149755.
    PubMed     Text format     Abstract available


  45. KUO YT, Chen CY, Liu GC, Wang YM, et al
    Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    PLoS One. 2016;11:e0148695.
    PubMed     Text format     Abstract available


  46. KIM SB, Kang OH, Lee YS, Han SH, et al
    Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice.
    PLoS One. 2016;11:e0147745.
    PubMed     Text format     Abstract available


  47. FAN X, Zhang X, Shen J, Zhao H, et al
    Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.
    PLoS One. 2016;11:e0149028.
    PubMed     Text format     Abstract available


  48. PETROPOLIS DB, Faust DM, Tolle M, Riviere L, et al
    Human Liver Infection in a Dish: Easy-To-Build 3D Liver Models for Studying Microbial Infection.
    PLoS One. 2016;11:e0148667.
    PubMed     Text format     Abstract available


  49. FUJIMOTO Y, Urashima T, Shimura D, Ito R, et al
    Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats.
    PLoS One. 2016;11:e0148666.
    PubMed     Text format     Abstract available


  50. XU J, Sayed BA, Casas-Ferreira AM, Srinivasan P, et al
    The Impact of Ischemia/Reperfusion Injury on Liver Allografts from Deceased after Cardiac Death versus Deceased after Brain Death Donors.
    PLoS One. 2016;11:e0148815.
    PubMed     Text format     Abstract available


  51. CARLSON N, Hommel K, Olesen JB, Soja AM, et al
    Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study.
    PLoS One. 2016;11:e0148809.
    PubMed     Text format     Abstract available


  52. WEI J, Lei GH, Fu L, Zeng C, et al
    Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
    PLoS One. 2016;11:e0147985.
    PubMed     Text format     Abstract available


  53. HANADA S, Iwata S, Kishi K, Morozumi M, et al
    Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease.
    PLoS One. 2016;11:e0147877.
    PubMed     Text format     Abstract available


  54. VENKATESAN N, Kanwar J, Deepa PR, Khetan V, et al
    Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
    PLoS One. 2016;11:e0146128.
    PubMed     Text format     Abstract available


  55. SHAO J, Xu Z, Peng X, Chen M, et al
    Gefitinib Synergizes with Irinotecan to Suppress Hepatocellular Carcinoma via Antagonizing Rad51-Mediated DNA-Repair.
    PLoS One. 2016;11:e0146968.
    PubMed     Text format     Abstract available


  56. ISHIDA T, Kotani H, Miyao M, Kawai C, et al
    Renal Impairment with Sublethal Tubular Cell Injury in a Chronic Liver Disease Mouse Model.
    PLoS One. 2016;11:e0146871.
    PubMed     Text format     Abstract available


  57. ANURACPREEDA P, Chawengkirttikul R, Sobhon P
    Immunodiagnosis of Fasciola gigantica Infection Using Monoclonal Antibody-Based Sandwich ELISA and Immunochromatographic Assay for Detection of Circulating Cathepsin L1 Protease.
    PLoS One. 2016;11:e0145650.
    PubMed     Text format     Abstract available


  58. ULITZKY L, Lafer MM, KuKuruga MA, Silberstein E, et al
    A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
    PLoS One. 2016;11:e0145212.
    PubMed     Text format     Abstract available


  59. GARCES-RIMON M, Gonzalez C, Uranga JA, Lopez-Miranda V, et al
    Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats.
    PLoS One. 2016;11:e0151193.
    PubMed     Text format     Abstract available


  60. LIU S, Xia Z, Liu J, Xu J, et al
    Automatic Multiple-Needle Surgical Planning of Robotic-Assisted Microwave Coagulation in Large Liver Tumor Therapy.
    PLoS One. 2016;11:e0149482.
    PubMed     Text format     Abstract available


  61. KOMIYA C, Tsuchiya K, Shiba K, Miyachi Y, et al
    Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    PLoS One. 2016;11:e0151511.
    PubMed     Text format     Abstract available


  62. FENG J, Zhu R, Chang C, Yu L, et al
    CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    PLoS One. 2016;11:e0151501.
    PubMed     Text format     Abstract available


  63. JIAO J, Watt GP, Lee M, Rahbar MH, et al
    Cirrhosis and Advanced Fibrosis in Hispanics in Texas: The Dominant Contribution of Central Obesity.
    PLoS One. 2016;11:e0150978.
    PubMed     Text format     Abstract available


  64. VERHAAG EM, Buist-Homan M, Koehorst M, Groen AK, et al
    Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    PLoS One. 2016;11:e0149782.
    PubMed     Text format     Abstract available


  65. HELLING G, Wahlin S, Smedberg M, Pettersson L, et al
    Plasma Glutamine Concentrations in Liver Failure.
    PLoS One. 2016;11:e0150440.
    PubMed     Text format     Abstract available


  66. ZWOLAK A, Slabczynska O, Semeniuk J, Daniluk J, et al
    Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies.
    PLoS One. 2016;11:e0150233.
    PubMed     Text format     Abstract available


  67. KNIGHT SR, Oniscu GC, Devey L, Simpson KJ, et al
    Use of Renal Replacement Therapy May Influence Graft Outcomes following Liver Transplantation for Acute Liver Failure: A Propensity-Score Matched Population-Based Retrospective Cohort Study.
    PLoS One. 2016;11:e0148782.
    PubMed     Text format     Abstract available


  68. ZENG T, Zhou J, He L, Zheng J, et al
    Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    PLoS One. 2016;11:e0149677.
    PubMed     Text format     Abstract available


  69. TAPPER EB, Hunink MG, Afdhal NH, Lai M, et al
    Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score.
    PLoS One. 2016;11:e0147237.
    PubMed     Text format     Abstract available


  70. HWANG SM, Jeon TY, Yoo SY, Kim JH, et al
    Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT.
    PLoS One. 2016;11:e0149681.
    PubMed     Text format     Abstract available


  71. VASQUES ER, Cunha JE, Coelho AM, Sampietre SN, et al
    Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion.
    PLoS One. 2016;11:e0149630.
    PubMed     Text format     Abstract available


  72. HAMETNER S, Ferlitsch A, Ferlitsch M, Etschmaier A, et al
    The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    PLoS One. 2016;11:e0149230.
    PubMed     Text format     Abstract available


  73. ARAUJO JUNIOR RF, Garcia VB, Leitao RF, Brito GA, et al
    Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells.
    PLoS One. 2016;11:e0148868.
    PubMed     Text format     Abstract available


  74. TAN Y, Liu X, Zhou K, He X, et al
    The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.
    PLoS One. 2016;11:e0149043.
    PubMed     Text format     Abstract available


  75. SU YC, Davuluri GV, Chen CH, Shiau DC, et al
    Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0148408.
    PubMed     Text format     Abstract available


  76. BONDE Y, Eggertsen G, Rudling M
    Mice Abundant in Muricholic Bile Acids Show Resistance to Dietary Induced Steatosis, Weight Gain, and to Impaired Glucose Metabolism.
    PLoS One. 2016;11:e0147772.
    PubMed     Text format     Abstract available


  77. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  78. BAUMGART DC, le Claire M
    The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds.
    PLoS One. 2016;11:e0147364.
    PubMed     Text format     Abstract available


  79. KONGKAVITOON P, Tangkijvanich P, Hirankarn N, Palaga T, et al
    Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146696.
    PubMed     Text format     Abstract available


  80. ITO H, Tanaka S, Akiyama Y, Shimada S, et al
    Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
    PLoS One. 2016;11:e0146564.
    PubMed     Text format     Abstract available


  81. LI M, Ye T, Wang XX, Li X, et al
    Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
    PLoS One. 2016;11:e0152085.
    PubMed     Text format     Abstract available


  82. ALT Y, Grimm A, Schlegel L, Grambihler A, et al
    The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.
    PLoS One. 2016;11:e0151200.
    PubMed     Text format     Abstract available


  83. JANG ES, Jeong SH, Kim JW, Choi YS, et al
    Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0151069.
    PubMed     Text format     Abstract available


  84. NALPAS B, Ichai P, Jamot L, Carbonell N, et al
    A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases.
    PLoS One. 2016;11:e0150733.
    PubMed     Text format     Abstract available


  85. CHEN QF, Chen HJ, Liu J, Sun T, et al
    Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity.
    PLoS One. 2016;11:e0151263.
    PubMed     Text format     Abstract available


  86. NAKAYAMA Y, Yamaguchi H, Einaga N, Esumi M, et al
    Pitfalls of DNA Quantification Using DNA-Binding Fluorescent Dyes and Suggested Solutions.
    PLoS One. 2016;11:e0150528.
    PubMed     Text format     Abstract available


  87. SIEGMUND SV, Schlosser M, Schildberg FA, Seki E, et al
    Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PLoS One. 2016;11:e0150893.
    PubMed     Text format     Abstract available


  88. ARYAL B, Shimizu T, Kadono J, Furoi A, et al
    A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans.
    PLoS One. 2016;11:e0150446.
    PubMed     Text format     Abstract available


  89. SONG H, Zheng Z, Wu J, Lai J, et al
    White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice.
    PLoS One. 2016;11:e0149670.
    PubMed     Text format     Abstract available


  90. URANBILEG B, Ikeda H, Kurano M, Enooku K, et al
    Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence.
    PLoS One. 2016;11:e0149462.
    PubMed     Text format     Abstract available


  91. HIROOKA M, Koizumi Y, Imai Y, Miyake T, et al
    Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation.
    PLoS One. 2016;11:e0148298.
    PubMed     Text format     Abstract available


  92. OMAR HA, Mohamed WR, Arab HH, Arafa el-SA, et al
    Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis.
    PLoS One. 2016;11:e0151649.
    PubMed     Text format     Abstract available


  93. ROMAN E, Garcia-Galceran C, Torrades T, Herrera S, et al
    Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis: A Randomized Clinical Trial.
    PLoS One. 2016;11:e0151652.
    PubMed     Text format     Abstract available


  94. TANG L, Zhu H, Yang X, Xie F, et al
    Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway.
    PLoS One. 2016;11:e0152012.
    PubMed     Text format     Abstract available


  95. PREUSSE M, Theis FJ, Mueller NS
    miTALOS v2: Analyzing Tissue Specific microRNA Function.
    PLoS One. 2016;11:e0151771.
    PubMed     Text format     Abstract available


  96. CHOW LN, Schreiner P, Ng BY, Lo B, et al
    Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
    PLoS One. 2016;11:e0151765.
    PubMed     Text format     Abstract available


  97. BAIOCCHINI A, Montaldo C, Conigliaro A, Grimaldi A, et al
    Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution.
    PLoS One. 2016;11:e0151736.
    PubMed     Text format     Abstract available


  98. ZHANG X, Wang Y, Han S, Xiang H, et al
    RY10-4 Inhibits the Proliferation of Human Hepatocellular Cancer HepG2 Cells by Inducing Apoptosis In Vitro and In Vivo.
    PLoS One. 2016;11:e0151679.
    PubMed     Text format     Abstract available


  99. FUJIBAYASHI K, Gunji T, Yokokawa H, Naito T, et al
    The Relationships between Metabolic Disorders (Hypertension, Dyslipidemia, and Impaired Glucose Tolerance) and Computed Tomography-Based Indices of Hepatic Steatosis or Visceral Fat Accumulation in Middle-Aged Japanese Men.
    PLoS One. 2016;11:e0149689.
    PubMed     Text format     Abstract available


  100. ROY N, Dasgupta D, Mukhopadhyay I, Chatterjee A, et al
    Genetic Association and Gene-Gene Interaction Reveal Genetic Variations in ADH1B, GSTM1 and MnSOD Independently Confer Risk to Alcoholic Liver Diseases in India.
    PLoS One. 2016;11:e0149843.
    PubMed     Text format     Abstract available


  101. AGEBRATT C, Strom E, Romu T, Dahlqvist-Leinhard O, et al
    A Randomized Study of the Effects of Additional Fruit and Nuts Consumption on Hepatic Fat Content, Cardiovascular Risk Factors and Basal Metabolic Rate.
    PLoS One. 2016;11:e0147149.
    PubMed     Text format     Abstract available


  102. TANG Y, Lv P, Sun Z, Han L, et al
    14-3-3beta Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-kappaB Pathway.
    PLoS One. 2016;11:e0146070.
    PubMed     Text format     Abstract available


  103. LI YL, Zhang J, Min D, Hongyan Z, et al
    Anticancer Effects of 1,3-Dihydroxy-2-Methylanthraquinone and the Ethyl Acetate Fraction of Hedyotis Diffusa Willd against HepG2 Carcinoma Cells Mediated via Apoptosis.
    PLoS One. 2016;11:e0151502.
    PubMed     Text format     Abstract available


  104. MATSUSHIMA-NISHIWAKI R, Toyoda H, Nagasawa T, Yasuda E, et al
    Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-alpha-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
    PLoS One. 2016;11:e0151907.
    PubMed     Text format     Abstract available


  105. NAWATA A, Noguchi H, Mazaki Y, Kurahashi T, et al
    Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0152549.
    PubMed     Text format     Abstract available


  106. LI J, Chen K, Li S, Liu T, et al
    Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis.
    PLoS One. 2016;11:e0152570.
    PubMed     Text format     Abstract available


  107. LAEMMLE A, Gallagher RC, Keogh A, Stricker T, et al
    Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD).
    PLoS One. 2016;11:e0153358.
    PubMed     Text format     Abstract available


  108. DASHTSOODOL N, Shigeura T, Ozawa R, Harada M, et al
    Generation of Novel Traj18-Deficient Mice Lacking Valpha14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire.
    PLoS One. 2016;11:e0153347.
    PubMed     Text format     Abstract available


  109. ESTRELA HF, Damasio ES, Fonseca EK, Bergamaschi CT, et al
    Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.
    PLoS One. 2016;11:e0152512.
    PubMed     Text format     Abstract available


  110. HUAN H, Wen X, Chen X, Wu L, et al
    C/EBPalpha Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/beta-Catenin Signaling Mediated EMT.
    PLoS One. 2016;11:e0153117.
    PubMed     Text format     Abstract available


  111. GHAGHADA KB, Sato AF, Starosolski ZA, Berg J, et al
    Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
    PLoS One. 2016;11:e0152718.
    PubMed     Text format     Abstract available


  112. OKABE H, Kinoshita H, Imai K, Nakagawa S, et al
    Diverse Basis of beta-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
    PLoS One. 2016;11:e0152695.
    PubMed     Text format     Abstract available


  113. REN J, Chen GG, Liu Y, Su X, et al
    Cytochrome P450 1A2 Metabolizes 17beta-Estradiol to Suppress Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0153863.
    PubMed     Text format     Abstract available


  114. SALVOZA NC, Klinzing DC, Gopez-Cervantes J, Baclig MO, et al
    Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0153497.
    PubMed     Text format     Abstract available


  115. MONTALBANO M, Curcuru G, Shirafkan A, Vento R, et al
    Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion.
    PLoS One. 2016;11:e0153613.
    PubMed     Text format     Abstract available


  116. CHIU HW, Hua KF
    Hepatoprotective Effect of Wheat-Based Solid-State Fermented Antrodia cinnamomea in Carbon Tetrachloride-Induced Liver Injury in Rat.
    PLoS One. 2016;11:e0153087.
    PubMed     Text format     Abstract available


  117. JUNG J, Yoon SM, Park HC, Nam TK, et al
    Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05).
    PLoS One. 2016;11:e0152642.
    PubMed     Text format     Abstract available


  118. NANTASANTI S, Toussaint MJ, Youssef SA, Tooten PC, et al
    Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor Suppression.
    PLoS One. 2016;11:e0150064.
    PubMed     Text format     Abstract available


  119. LI C, Li P, Tan YM, Lam SH, et al
    Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish.
    PLoS One. 2016;11:e0151225.
    PubMed     Text format     Abstract available


  120. XIE F, Li ZP, Wang HW, Fei X, et al
    Evaluation of Liver Ischemia-Reperfusion Injury in Rabbits Using a Nanoscale Ultrasound Contrast Agent Targeting ICAM-1.
    PLoS One. 2016;11:e0153805.
    PubMed     Text format     Abstract available


  121. SHEARN CT, Orlicky DJ, McCullough RL, Jiang H, et al
    Liver-Specific Deletion of Phosphatase and Tensin Homolog Deleted on Chromosome 10 Significantly Ameliorates Chronic EtOH-Induced Increases in Hepatocellular Damage.
    PLoS One. 2016;11:e0154152.
    PubMed     Text format     Abstract available


  122. SANTAREM OL, Cleva Rd, Sasaya FM, Assumpcao MS, et al
    Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.
    PLoS One. 2016;11:e0154011.
    PubMed     Text format     Abstract available


  123. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    PubMed     Text format     Abstract available


  124. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    PubMed     Text format     Abstract available


  125. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    PubMed     Text format     Abstract available


  126. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    PubMed     Text format     Abstract available


  127. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    PubMed     Text format     Abstract available


  128. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available


    January 2015
  129. HONG M, Kim SW, Han SH, Kim DJ, et al
    Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) Reduce the Expression of Toll-Like Receptor 4 in Mice with Alcoholic Liver Disease.
    PLoS One. 2015;10:e0117451.
    PubMed     Text format     Abstract available


  130. GOMEZ-ANSON B, Roman E, Fernandez de Bobadilla R, Pires-Encuentra P, et al
    Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.
    PLoS One. 2015;10:e0118930.
    PubMed     Text format     Abstract available


  131. MENG Y, Liang Y, Liu M
    The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis.
    PLoS One. 2015;10:e0120110.
    PubMed     Text format     Abstract available


  132. CHEN G, Lu L, Liu C, Shan L, et al
    MicroRNA-377 suppresses cell proliferation and invasion by inhibiting TIAM1 expression in hepatocellular carcinoma.
    PLoS One. 2015;10:e0117714.
    PubMed     Text format     Abstract available


  133. HSU CY, Liu PH, Lee YH, Hsia CY, et al
    Using serum alpha-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?
    PLoS One. 2015;10:e0118825.
    PubMed     Text format     Abstract available


  134. LI J, Chanrion M, Sawey E, Wang T, et al
    Reciprocal interaction of Wnt and RXR-alpha pathways in hepatocyte development and hepatocellular carcinoma.
    PLoS One. 2015;10:e0118480.
    PubMed     Text format     Abstract available


  135. HASHIZUME O, Yamanashi H, Taketo MM, Nakada K, et al
    A Specific Nuclear DNA Background Is Required for High Frequency Lymphoma Development in Transmitochondrial Mice with G13997A mtDNA.
    PLoS One. 2015;10:e0118561.
    PubMed     Text format     Abstract available


  136. LIM YP, Lin CL, Lin YN, Ma WC, et al
    Antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.
    PLoS One. 2015;10:e0116960.
    PubMed     Text format     Abstract available


  137. HEIJMEN L, Ter Voert EE, Oyen WJ, Punt CJ, et al
    Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer.
    PLoS One. 2015;10:e0120823.
    PubMed     Text format     Abstract available


  138. ANG SF, Ng ES, Li H, Ong YH, et al
    The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.
    PLoS One. 2015;10:e0118658.
    PubMed     Text format     Abstract available


  139. ZHANG T, Kho DH, Wang Y, Harazono Y, et al
    Gp78, an E3 ubiquitin ligase acts as a gatekeeper suppressing nonalcoholic steatohepatitis (NASH) and liver cancer.
    PLoS One. 2015;10:e0118448.
    PubMed     Text format     Abstract available


  140. WU JR, Hu CT, You RI, Ma PL, et al
    Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.
    PLoS One. 2015;10:e0114495.
    PubMed     Text format     Abstract available


  141. HOFFMANN CJ, Hoffmann JD, Kensler C, van der Watt M, et al
    Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa.
    PLoS One. 2015;10:e0117813.
    PubMed     Text format     Abstract available


  142. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  143. SPEISER JL, Lee WM, Karvellas CJ
    Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models.
    PLoS One. 2015;10:e0122929.
    PubMed     Text format     Abstract available


  144. JING Y, Wu K, Liu J, Ai Q, et al
    Aminotriazole Alleviates Acetaminophen Poisoning via Downregulating P450 2E1 and Suppressing Inflammation.
    PLoS One. 2015;10:e0122781.
    PubMed     Text format     Abstract available


  145. LIN YY, Shiau S, Fang CT
    Risk Factors for Invasive Cryptococcus neoformans Diseases: A Case-Control Study.
    PLoS One. 2015;10:e0119090.
    PubMed     Text format     Abstract available


  146. WU YC, Lo HY, Yang SL, Chu DC, et al
    Comparing the Factors Correlated with Tuberculosis-Specific and Non-Tuberculosis-Specific Deaths in Different Age Groups among Tuberculosis-Related Deaths in Taiwan.
    PLoS One. 2015;10:e0118929.
    PubMed     Text format     Abstract available


  147. PARK M, Chung YE, Kim KA, Chung WS, et al
    Added value of arterial enhancement fraction color maps for the characterization of small hepatic low-attenuating lesions in patients with colorectal cancer.
    PLoS One. 2015;10:e0114819.
    PubMed     Text format     Abstract available


  148. HU H, Duan Z, Long X, Hertzanu Y, et al
    Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching study.
    PLoS One. 2015;10:e0117168.
    PubMed     Text format     Abstract available


  149. ZHANG L, Song H, Ge Y, Ji G, et al
    Temporal relationship between diet-induced steatosis and onset of insulin/leptin resistance in male Wistar rats.
    PLoS One. 2015;10:e0117008.
    PubMed     Text format     Abstract available


  150. RING M, Eskofier BM
    Data mining in the U.S. National Toxicology Program (NTP) database reveals a potential bias regarding liver tumors in rodents irrespective of the test agent.
    PLoS One. 2015;10:e0116488.
    PubMed     Text format     Abstract available


  151. DONGIOVANNI P, Lanti C, Gatti S, Rametta R, et al
    High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload.
    PLoS One. 2015;10:e0116855.
    PubMed     Text format     Abstract available


  152. KOEPKE J, Dresel M, Schmid S, Greulich T, et al
    Therapy with plasma purified alpha1-antitrypsin (Prolastin(R)) induces time-dependent changes in plasma levels of MMP-9 and MPO.
    PLoS One. 2015;10:e0117497.
    PubMed     Text format     Abstract available


  153. JIANG L, Zhang Q, Ren H, Ma S, et al
    Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
    PLoS One. 2015;10:e0124994.
    PubMed     Text format     Abstract available


  154. LI LY, Yang WM, Chen HZ, Wu YH, et al
    Successful Splenectomy for Hypersplenism in Wilson's Disease: A Single Center Experience from China.
    PLoS One. 2015;10:e0124569.
    PubMed     Text format     Abstract available


  155. DECARIS ML, Emson CL, Li K, Gatmaitan M, et al
    Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease.
    PLoS One. 2015;10:e0123311.
    PubMed     Text format     Abstract available


  156. ZHU X, Wu L, Yao J, Jiang H, et al
    MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0124266.
    PubMed     Text format     Abstract available


  157. DONG H, Zhang L, Qian Z, Zhu X, et al
    Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0123175.
    PubMed     Text format     Abstract available


  158. ZHE C, Yu F, Tian J, Zheng S, et al
    Trps1 regulates biliary epithelial-mesenchymal transition and has roles during biliary fibrosis in liver grafts: a preliminary study.
    PLoS One. 2015;10:e0123233.
    PubMed     Text format     Abstract available


  159. AHRONIAN LG, Driscoll DR, Klimstra DS, Lewis BC, et al
    The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.
    PLoS One. 2015;10:e0123816.
    PubMed     Text format     Abstract available


  160. RAYMOND AA, Benhamouche S, Neaud V, Di Martino J, et al
    Reptin regulates DNA double strand breaks repair in human hepatocellular carcinoma.
    PLoS One. 2015;10:e0123333.
    PubMed     Text format     Abstract available


  161. GAO M, Ma Y, Liu D
    High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice.
    PLoS One. 2015;10:e0119784.
    PubMed     Text format     Abstract available


  162. TAN C, Liu S, Tan S, Zeng X, et al
    Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.
    PLoS One. 2015;10:e0119210.
    PubMed     Text format     Abstract available


  163. SUMI A, Akiba J, Ogasawara S, Nakayama M, et al
    Des-gamma-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.
    PLoS One. 2015;10:e0118452.
    PubMed     Text format     Abstract available


  164. HUANG WJ, Jeng YM, Lai HS, Fong IU, et al
    Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2015;10:e0119181.
    PubMed     Text format     Abstract available


  165. LI W, Yu J, Lian B, Sun H, et al
    Identifying prognostic features by bottom-up approach and correlating to drug repositioning.
    PLoS One. 2015;10:e0118672.
    PubMed     Text format     Abstract available


  166. FANG Z, Zhou L, Jiang S, Cao L, et al
    UNC50 prompts G1/S transition and proliferation in HCC by regulation of epidermal growth factor receptor trafficking.
    PLoS One. 2015;10:e0119338.
    PubMed     Text format     Abstract available


  167. HOCHST B, Mikulec J, Baccega T, Metzger C, et al
    Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis.
    PLoS One. 2015;10:e0119662.
    PubMed     Text format     Abstract available


  168. DUPRE A, Melodelima D, Perol D, Chen Y, et al
    First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study.
    PLoS One. 2015;10:e0118212.
    PubMed     Text format     Abstract available


  169. BUSBEE PB, Nagarkatti M, Nagarkatti PS
    Natural Indoles, Indole-3-Carbinol (I3C) and 3,3'-Diindolylmethane (DIM), Attenuate Staphylococcal Enterotoxin B-Mediated Liver Injury by Downregulating miR-31 Expression and Promoting Caspase-2-Mediated Apoptosis.
    PLoS One. 2015;10:e0118506.
    PubMed     Text format     Abstract available


  170. POURHOSEINI S, Seth RK, Das S, Dattaroy D, et al
    Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.
    PLoS One. 2015;10:e0116780.
    PubMed     Text format     Abstract available


  171. TSAI HC, Lin YC, Ko CL, Lou HY, et al
    Propofol versus Midazolam for Upper Gastrointestinal Endoscopy in Cirrhotic Patients: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2015;10:e0117585.
    PubMed     Text format     Abstract available


  172. KENERSON HL, Subramanian S, McIntyre R, Kazami M, et al
    Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.
    PLoS One. 2015;10:e0117000.
    PubMed     Text format     Abstract available


  173. TUNG HC, Lee FY, Wang SS, Tsai MH, et al
    The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
    PLoS One. 2015;10:e0124654.
    PubMed     Text format     Abstract available


  174. HATZIAGELAKI E, Herder C, Tsiavou A, Teichert T, et al
    Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
    PLoS One. 2015;10:e0124935.
    PubMed     Text format     Abstract available


  175. YANG J, Li X, Yang R, Yu X, et al
    Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
    PLoS One. 2015;10:e0125100.
    PubMed     Text format     Abstract available


  176. WAN S, Wu Y, Zhou X, Chen Y, et al
    Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0124471.
    PubMed     Text format     Abstract available


  177. DE NIZ M, Helm S, Horstmann S, Annoura T, et al
    In vivo and in vitro characterization of a Plasmodium liver stage-specific promoter.
    PLoS One. 2015;10:e0123473.
    PubMed     Text format     Abstract available


  178. SHABANI P, Naeimi Khaledi H, Beigy M, Emamgholipour S, et al
    Circulating level of CTRP1 in patients with nonalcoholic fatty liver disease (NAFLD): is it through insulin resistance?
    PLoS One. 2015;10:e0118650.
    PubMed     Text format     Abstract available


  179. FAN W, Zhang Y, Wang Y, Yao X, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization.
    PLoS One. 2015;10:e0119312.
    PubMed     Text format     Abstract available


  180. TIVERS MS, Handel I, Gow AG, Lipscomb VJ, et al
    Attenuation of congenital portosystemic shunt reduces inflammation in dogs.
    PLoS One. 2015;10:e0117557.
    PubMed     Text format     Abstract available


  181. CHA YL, Li PD, Yuan LJ, Zhang MY, et al
    EIF4EBP1 overexpression is associated with poor survival and disease progression in patients with hepatocellular carcinoma.
    PLoS One. 2015;10:e0117493.
    PubMed     Text format     Abstract available


  182. ANOTA A, Mouillet G, Trouilloud I, Dupont-Gossart AC, et al
    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
    PLoS One. 2015;10:e0125350.
    PubMed     Text format     Abstract available


  183. GUO Z, Zhang J, Jiang JH, Li LQ, et al
    Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.
    PLoS One. 2015;10:e0125649.
    PubMed     Text format     Abstract available


  184. PARENTE DB, Paiva FF, Oliveira Neto JA, Machado-Silva L, et al
    Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients.
    PLoS One. 2015;10:e0125653.
    PubMed     Text format     Abstract available


  185. KURT R, Chandra PK, Aboulnasr F, Panigrahi R, et al
    Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    PLoS One. 2015;10:e0125962.
    PubMed     Text format     Abstract available


  186. BERTHELIER V, Harris JB, Estenson KN, Baudry J, et al
    Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.
    PLoS One. 2015;10:e0126256.
    PubMed     Text format     Abstract available


  187. MARCAN M, Kos B, Miklavcic D
    Effect of blood vessel segmentation on the outcome of electroporation-based treatments of liver tumors.
    PLoS One. 2015;10:e0125591.
    PubMed     Text format     Abstract available


  188. XU J, Teng IT, Zhang L, Delgado S, et al
    Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.
    PLoS One. 2015;10:e0125863.
    PubMed     Text format     Abstract available


  189. AKIE TE, Liu L, Nam M, Lei S, et al
    OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0125617.
    PubMed     Text format     Abstract available


  190. YANG BL, Wu WC, Fang KC, Wang YC, et al
    External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan.
    PLoS One. 2015;10:e0120443.
    PubMed     Text format     Abstract available


  191. CHEN YL, Lin HC, Lin KH, Lin LS, et al
    Low hemoglobin level is associated with the development of delirium after hepatectomy for hepatocellular carcinoma patients.
    PLoS One. 2015;10:e0119199.
    PubMed     Text format     Abstract available


  192. LOUREIRO CL, Aguilar JC, Aguiar J, Muzio V, et al
    HBV genotypic variability in Cuba.
    PLoS One. 2015;10:e0118959.
    PubMed     Text format     Abstract available


  193. CHEN Z, Zhu J, Huang C, Lian F, et al
    The association between three cyclooxygenase-2 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
    PLoS One. 2015;10:e0118251.
    PubMed     Text format     Abstract available


  194. CHEN J, Wu M, Liu R, Li S, et al
    Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.
    PLoS One. 2015;10:e0117661.
    PubMed     Text format     Abstract available


  195. D'ARCANGELO M, Todaro M, Salvini J, Benfante A, et al
    Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.
    PLoS One. 2015;10:e0125037.
    PubMed     Text format     Abstract available


  196. KNABEL MK, Ramachandran K, Karhadkar S, Hwang HW, et al
    Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    PLoS One. 2015;10:e0124411.
    PubMed     Text format     Abstract available


  197. BOGAERTS E, Heindryckx F, Devisscher L, Paridaens A, et al
    Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors.
    PLoS One. 2015;10:e0119555.
    PubMed     Text format     Abstract available


  198. FRADES I, Andreasson E, Mato JM, Alexandersson E, et al
    Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.
    PLoS One. 2015;10:e0124544.
    PubMed     Text format     Abstract available


  199. MOELLER M, Thonig A, Pohl S, Ripoll C, et al
    Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
    PLoS One. 2015;10:e0121229.
    PubMed     Text format     Abstract available


  200. SCHWEIGER T, Nikolowsky C, Starlinger P, Traxler D, et al
    Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
    PLoS One. 2015;10:e0120724.
    PubMed     Text format     Abstract available


  201. ZHANG Q, Li Y, Han T, Nie C, et al
    Comparison of current diagnostic criteria for acute-on-chronic liver failure.
    PLoS One. 2015;10:e0122158.
    PubMed     Text format     Abstract available


  202. RIGALLI JP, Ciriaci N, Arias A, Ceballos MP, et al
    Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity.
    PLoS One. 2015;10:e0119502.
    PubMed     Text format     Abstract available


  203. FENG D, Youn DY, Zhao X, Gao Y, et al
    mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
    PLoS One. 2015;10:e0126240.
    PubMed     Text format     Abstract available


  204. IMAI N, Suzuki M, Hayashi K, Ishigami M, et al
    Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.
    PLoS One. 2015;10:e0127114.
    PubMed     Text format     Abstract available


  205. KIM SH, Wu SY, Baek JI, Choi SY, et al
    A post-developmental genetic screen for zebrafish models of inherited liver disease.
    PLoS One. 2015;10:e0125980.
    PubMed     Text format     Abstract available


  206. JANG JW, Kim YW, Lee SW, Kwon JH, et al
    Reactivation of Hepatitis B Virus in HBsAg-Negative Patients with Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0122041.
    PubMed     Text format     Abstract available


  207. CHOI JE, Kwon JH, Kim JH, Hur W, et al
    Suppression of dual specificity phosphatase I expression inhibits hepatitis C virus replication.
    PLoS One. 2015;10:e0119172.
    PubMed     Text format     Abstract available


  208. OGATA Y, Matono K, Tsuda H, Ushijima M, et al
    Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer.
    PLoS One. 2015;10:e0120064.
    PubMed     Text format     Abstract available


  209. JHARAP B, van Asseldonk DP, de Boer NK, Bedossa P, et al
    Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.
    PLoS One. 2015;10:e0120299.
    PubMed     Text format     Abstract available


  210. LU L, Zhou J, Shi J, Peng XJ, et al
    Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
    PLoS One. 2015;10:e0127524.
    PubMed     Text format     Abstract available


  211. MERLI M, Lucidi C, Di Gregorio V, Falcone M, et al
    The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.
    PLoS One. 2015;10:e0127448.
    PubMed     Text format     Abstract available


  212. LIN WC, Hsu TW, Chen CL, Lu CH, et al
    Resting State-fMRI with ReHo Analysis as a Non-Invasive Modality for the Prognosis of Cirrhotic Patients with Overt Hepatic Encephalopathy.
    PLoS One. 2015;10:e0126834.
    PubMed     Text format     Abstract available


  213. ZAKRZEWSKA KE, Samluk A, Wierzbicki M, Jaworski S, et al
    Analysis of the cytotoxicity of carbon-based nanoparticles, diamond and graphite, in human glioblastoma and hepatoma cell lines.
    PLoS One. 2015;10:e0122579.
    PubMed     Text format     Abstract available


  214. MARTEL G, Hawel J, Rekman J, Croome KP, et al
    Liver resection for non-colorectal, non-carcinoid, non-sarcoma metastases: a multicenter study.
    PLoS One. 2015;10:e0120569.
    PubMed     Text format     Abstract available


  215. CHANG CH, Chen YC, Zhang W, Leung PS, et al
    Innate immunity drives the initiation of a murine model of primary biliary cirrhosis.
    PLoS One. 2015;10:e0121320.
    PubMed     Text format     Abstract available


  216. LIN X, Jia J, Du T, Li W, et al
    Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism.
    PLoS One. 2015;10:e0118417.
    PubMed     Text format     Abstract available


  217. HE L, Gao L, Shi Z, Li Y, et al
    Involvement of Cytochrome P450 1A1 and Glutathione S-Transferase P1 Polymorphisms and Promoter Hypermethylation in the Progression of Anti-Tuberculosis Drug-Induced Liver Injury: A Case-Control Study.
    PLoS One. 2015;10:e0119481.
    PubMed     Text format     Abstract available


  218. CAI L, Cai MH, Wang MY, Xu YF, et al
    Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms.
    PLoS One. 2015;10:e0128643.
    PubMed     Text format     Abstract available


  219. ZHANG J, Chong CC, Chen GG, Lai PB, et al
    A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0128628.
    PubMed     Text format     Abstract available


  220. NEZAMI RANJBAR MR, Luo Y, Di Poto C, Varghese RS, et al
    GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort.
    PLoS One. 2015;10:e0127299.
    PubMed     Text format     Abstract available


  221. LI J, Hernanda PY, Bramer WM, Peppelenbosch MP, et al
    Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0127967.
    PubMed     Text format     Abstract available


  222. LIN CM, Huang HL, Chu FY, Fan HC, et al
    Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
    PLoS One. 2015;10:e0125421.
    PubMed     Text format     Abstract available


  223. JIN P, Chen Y, Lv L, Yang J, et al
    Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-alpha Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.
    PLoS One. 2015;10:e0126520.
    PubMed     Text format     Abstract available


  224. LIANG T, Alloosh M, Bell LN, Fullenkamp A, et al
    Liver injury and fibrosis induced by dietary challenge in the Ossabaw miniature Swine.
    PLoS One. 2015;10:e0124173.
    PubMed     Text format     Abstract available


  225. CHIU KW, Nakano T, Chen KD, Hsu LW, et al
    Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.
    PLoS One. 2015;10:e0124943.
    PubMed     Text format     Abstract available


  226. BEIER JI, Jokinen JD, Holz GE, Whang PS, et al
    Novel mechanism of arenavirus-induced liver pathology.
    PLoS One. 2015;10:e0122839.
    PubMed     Text format     Abstract available


  227. KONUMA K, Itoh M, Suganami T, Kanai S, et al
    Eicosapentaenoic Acid ameliorates non-alcoholic steatohepatitis in a novel mouse model using melanocortin 4 receptor-deficient mice.
    PLoS One. 2015;10:e0121528.
    PubMed     Text format     Abstract available


  228. SCOTT C, Cha K, Rao R, Liddle C, et al
    Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.
    PLoS One. 2015;10:e0121650.
    PubMed     Text format     Abstract available


  229. EL-SAYED YS, Lebda MA, Hassinin M, Neoman SA, et al
    Chicory (Cichorium intybus L.) root extract regulates the oxidative status and antioxidant gene transcripts in CCl4-induced hepatotoxicity.
    PLoS One. 2015;10:e0121549.
    PubMed     Text format     Abstract available


  230. SEBASTIANI G, Alshaalan R, Wong P, Rubino M, et al
    Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
    PLoS One. 2015;10:e0128774.
    PubMed     Text format     Abstract available


  231. ALTEKRUSE SF, Petrick JL, Rolin AI, Cuccinelli JE, et al
    Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    PLoS One. 2015;10:e0120574.
    PubMed     Text format     Abstract available


  232. KAYSER BD, Goran MI, Bouret SG
    Perinatal overnutrition exacerbates adipose tissue inflammation caused by high-fat feeding in C57BL/6J mice.
    PLoS One. 2015;10:e0121954.
    PubMed     Text format     Abstract available


  233. CAI ZQ, Si SB, Chen C, Zhao Y, et al
    Analysis of prognostic factors for survival after hepatectomy for hepatocellular carcinoma based on a bayesian network.
    PLoS One. 2015;10:e0120805.
    PubMed     Text format     Abstract available


  234. LIU YY, Li CP, Huai MS, Fu XM, et al
    Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
    PLoS One. 2015;10:e0120939.
    PubMed     Text format     Abstract available


  235. KIM HM, Lee ES, Lee BR, Yadav D, et al
    C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model.
    PLoS One. 2015;10:e0120711.
    PubMed     Text format     Abstract available


  236. SONG B, Bian Q, Shao CH, Li G, et al
    Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
    PLoS One. 2015;10:e0120694.
    PubMed     Text format     Abstract available


  237. STRICK-MARCHAND H, Dusseaux M, Darche S, Huntington ND, et al
    A novel mouse model for stable engraftment of a human immune system and human hepatocytes.
    PLoS One. 2015;10:e0119820.
    PubMed     Text format     Abstract available


  238. JAMES MI, Howells LM, Karmokar A, Higgins JA, et al
    Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
    PLoS One. 2015;10:e0117776.
    PubMed     Text format     Abstract available


  239. HIRASAWA M, Hagihara K, Okudaira N, Izumi T, et al
    The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01.
    PLoS One. 2015;10:e0130928.
    PubMed     Text format     Abstract available


  240. HU Z, Wan X, Hao R, Zhang H, et al
    Phosphorylation of mutationally introduced tyrosine in the activation loop of HER2 confers gain-of-function activity.
    PLoS One. 2015;10:e0123623.
    PubMed     Text format     Abstract available


  241. WHITE SB, Chen J, Gordon AC, Harris KR, et al
    Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.
    PLoS One. 2015;10:e0123888.
    PubMed     Text format     Abstract available


  242. PARK Y, Kim SU, Park SY, Kim BK, et al
    A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography.
    PLoS One. 2015;10:e0121009.
    PubMed     Text format     Abstract available


  243. JEONG WK, Kim TY, Sohn JH, Kim Y, et al
    Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.
    PLoS One. 2015;10:e0121601.
    PubMed     Text format     Abstract available


  244. YANG M, Xu D, Liu Y, Guo X, et al
    Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0131664.
    PubMed     Text format     Abstract available


  245. KASZTELAN-SZCZERBINSKA B, Surdacka A, Celinski K, Rolinski J, et al
    Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences.
    PLoS One. 2015;10:e0128347.
    PubMed     Text format     Abstract available


  246. SHEU MJ, Hsieh MJ, Chiang WL, Yang SF, et al
    Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
    PLoS One. 2015;10:e0122961.
    PubMed     Text format     Abstract available


  247. XIA W, Chen W, Zhang Z, Wu D, et al
    Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis.
    PLoS One. 2015;10:e0123484.
    PubMed     Text format     Abstract available


  248. LIU H, Fu J, Hong R, Liu L, et al
    Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.
    PLoS One. 2015;10:e0127782.
    PubMed     Text format     Abstract available


  249. TALIB WH, Saleh S
    Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice.
    PLoS One. 2015;10:e0124384.
    PubMed     Text format     Abstract available


  250. JAGER S, Jacobs S, Kroger J, Stefan N, et al
    Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.
    PLoS One. 2015;10:e0124749.
    PubMed     Text format     Abstract available


  251. SOARES E SILVA AK, de Oliveira Cipriano Torres D, Dos Santos Gomes FO, Dos Santos Silva B, et al
    LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD).
    PLoS One. 2015;10:e0123787.
    PubMed     Text format     Abstract available


  252. LI R, Tang CL, Zhang Y, Ma KS, et al
    Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients.
    PLoS One. 2015;10:e0132290.
    PubMed     Text format     Abstract available


  253. FINKELMEIER F, Kronenberger B, Zeuzem S, Piiper A, et al
    Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis.
    PLoS One. 2015;10:e0132119.
    PubMed     Text format     Abstract available


  254. MEIKLE PJ, Mundra PA, Wong G, Rahman K, et al
    Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    PLoS One. 2015;10:e0130346.
    PubMed     Text format     Abstract available


  255. XING H, Jia K, He J, Shi C, et al
    Establishment of the tree shrew as an alcohol-induced Fatty liver model for the study of alcoholic liver diseases.
    PLoS One. 2015;10:e0128253.
    PubMed     Text format     Abstract available


  256. LIU X, Wang Y, Ming Y, Song Y, et al
    S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0127352.
    PubMed     Text format     Abstract available


  257. OHNO T, Shimizu M, Shirakami Y, Baba A, et al
    Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Leprdb/+Leprdb Mice.
    PLoS One. 2015;10:e0124081.
    PubMed     Text format     Abstract available


  258. ZHANG AY, Lai CL, Huang FY, Seto WK, et al
    Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0139478.
    PubMed     Text format     Abstract available


  259. KIMURA T, Takahashi S, Takahashi I, Nishibuchi I, et al
    The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0125231.
    PubMed     Text format     Abstract available


  260. KASUMOV T, Li L, Li M, Gulshan K, et al
    Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.
    PLoS One. 2015;10:e0126910.
    PubMed     Text format     Abstract available


  261. ORNELLAS F, Souza-Mello V, Mandarim-de-Lacerda CA, Aguila MB, et al
    Programming of Obesity and Comorbidities in the Progeny: Lessons from a Model of Diet-Induced Obese Parents.
    PLoS One. 2015;10:e0124737.
    PubMed     Text format     Abstract available


  262. TAKANO Y, Kasai K, Takagishi Y, Kikumori T, et al
    Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides.
    PLoS One. 2015;10:e0133812.
    PubMed     Text format     Abstract available


  263. SEKIGUCHI T, Umemura T, Fujimori N, Shibata S, et al
    Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis.
    PLoS One. 2015;10:e0131658.
    PubMed     Text format     Abstract available


  264. SHEN Z, Munker S, Luo F, Ma H, et al
    Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age.
    PLoS One. 2015;10:e0130614.
    PubMed     Text format     Abstract available


  265. CHEN J, Zhang X, Xu Y, Li X, et al
    Hepatic Progenitor Cells Contribute to the Progression of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis via the Non-Canonical Wnt Pathway.
    PLoS One. 2015;10:e0130310.
    PubMed     Text format     Abstract available


  266. ZHANG W, Shi X, Peng Y, Wu M, et al
    HIF-1alpha Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
    PLoS One. 2015;10:e0129603.
    PubMed     Text format     Abstract available


  267. LAPADULA G, Chatenoud L, Gori A, Castelli F, et al
    Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/mul Despite Effective HAART.
    PLoS One. 2015;10:e0124741.
    PubMed     Text format     Abstract available


  268. LIM N, Lidofsky SD
    Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis.
    PLoS One. 2015;10:e0123490.
    PubMed     Text format     Abstract available


  269. CHEN H, Liu L, Qi X, He C, et al
    Imbalance of Pro- vs. Anti-Coagulation Factors in Chinese Patients with Budd-Chiari Syndrome and Non-Cirrhotic Portal Vein Thrombosis.
    PLoS One. 2015;10:e0119909.
    PubMed     Text format     Abstract available


  270. CAPONE F, Guerriero E, Colonna G, Maio P, et al
    The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes.
    PLoS One. 2015;10:e0134594.
    PubMed     Text format     Abstract available


  271. QIN Y, Zhou Y, Chen SH, Zhao XL, et al
    Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    PLoS One. 2015;10:e0133496.
    PubMed     Text format     Abstract available


  272. ONIKI K, Saruwatari J, Izuka T, Kajiwara A, et al
    Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
    PLoS One. 2015;10:e0132640.
    PubMed     Text format     Abstract available


  273. HABKA D, Mann D, Landes R, Soto-Gutierrez A, et al
    Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts.
    PLoS One. 2015;10:e0131764.
    PubMed     Text format     Abstract available


  274. SODHI K, Puri N, Favero G, Stevens S, et al
    Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    PLoS One. 2015;10:e0128648.
    PubMed     Text format     Abstract available


  275. ARIZA X, Sola E, Elia C, Barreto R, et al
    Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis.
    PLoS One. 2015;10:e0128145.
    PubMed     Text format     Abstract available


  276. HSIEH CJ, Wang PW, Hu TH
    Association of Adiponectin Gene Polymorphism with Nonalcoholic Fatty Liver Disease in Taiwanese Patients with Type 2 Diabetes.
    PLoS One. 2015;10:e0127521.
    PubMed     Text format     Abstract available


  277. INAFUKU M, Matsuzaki G, Oku H
    Intravenous Mycobacterium Bovis Bacillus Calmette-Guerin Ameliorates Nonalcoholic Fatty Liver Disease in Obese, Diabetic ob/ob Mice.
    PLoS One. 2015;10:e0128676.
    PubMed     Text format     Abstract available


  278. FLASS T, Tong S, Frank DN, Wagner BD, et al
    Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis.
    PLoS One. 2015;10:e0116967.
    PubMed     Text format     Abstract available


  279. PARK MH, Shim HS, Kim WH, Kim HJ, et al
    Clinical Risk Scoring Models for Prediction of Acute Kidney Injury after Living Donor Liver Transplantation: A Retrospective Observational Study.
    PLoS One. 2015;10:e0136230.
    PubMed     Text format     Abstract available


  280. LONG X, Chen Q, Zhao J, Rafaels N, et al
    An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum.
    PLoS One. 2015;10:e0135360.
    PubMed     Text format     Abstract available


  281. YAN HM, Xia MF, Wang Y, Chang XX, et al
    Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0134172.
    PubMed     Text format     Abstract available


  282. SHIE FS, Shiao YJ, Yeh CW, Lin CH, et al
    Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 Mice.
    PLoS One. 2015;10:e0134531.
    PubMed     Text format     Abstract available


  283. CHO EJ, Kim MY, Lee JH, Lee IY, et al
    Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis.
    PLoS One. 2015;10:e0133935.
    PubMed     Text format     Abstract available


  284. SANCHEZ-ANTOLIN G, Almohalla-Alvarez C, Bueno P, Almansa R, et al
    Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis.
    PLoS One. 2015;10:e0137128.
    PubMed     Text format     Abstract available


  285. HADDAD L, Cassenote AJ, Andraus W, de Martino RB, et al
    Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach.
    PLoS One. 2015;10:e0134874.
    PubMed     Text format     Abstract available


  286. KLEIN S, Herath CB, Schierwagen R, Grace J, et al
    Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis.
    PLoS One. 2015;10:e0138732.
    PubMed     Text format     Abstract available


  287. LIM EJ, Chin R, Nachbur U, Silke J, et al
    Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
    PLoS One. 2015;10:e0138522.
    PubMed     Text format     Abstract available


  288. KERBERT AJ, Verbeke L, Chiang FW, Laleman W, et al
    Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis.
    PLoS One. 2015;10:e0138264.
    PubMed     Text format     Abstract available


  289. MEI L, Tang Y, Li M, Yang P, et al
    Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver.
    PLoS One. 2015;10:e0138078.
    PubMed     Text format     Abstract available


  290. THEYSOHN JM, Ruhlmann M, Muller S, Dechene A, et al
    Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
    PLoS One. 2015;10:e0137587.
    PubMed     Text format     Abstract available


  291. BEIDERWELLEN K, Geraldo L, Ruhlmann V, Heusch P, et al
    Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
    PLoS One. 2015;10:e0137285.
    PubMed     Text format     Abstract available


  292. JUNG YY, Kim HM, Koo JS
    Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
    PLoS One. 2015;10:e0137204.
    PubMed     Text format     Abstract available


  293. ZHENG S, Lu Q, Xu Y, Wang X, et al
    GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver.
    PLoS One. 2015;10:e0132222.
    PubMed     Text format     Abstract available


  294. MORRISON MC, Mulder P, Stavro PM, Suarez M, et al
    Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil.
    PLoS One. 2015;10:e0139196.
    PubMed     Text format     Abstract available


  295. ZHANG H, Li Y, Hu J, Shen WJ, et al
    Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis.
    PLoS One. 2015;10:e0138203.
    PubMed     Text format     Abstract available


  296. GRAMMATIKOS G, Ferreiros N, Waidmann O, Bon D, et al
    Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis.
    PLoS One. 2015;10:e0138130.
    PubMed     Text format     Abstract available


  297. MANTOVANI A, Pernigo M, Bergamini C, Bonapace S, et al
    Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes.
    PLoS One. 2015;10:e0135329.
    PubMed     Text format     Abstract available


  298. CHEN LX, Ning GZ, Zhou ZR, Li YL, et al
    The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies.
    PLoS One. 2015;10:e0123080.
    PubMed     Text format     Abstract available


  299. LIN P, Lu J, Wang Y, Gu W, et al
    Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis.
    PLoS One. 2015;10:e0140346.
    PubMed     Text format     Abstract available


  300. CROOME KP, Lee DD, Burns JM, Perry DK, et al
    Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States.
    PLoS One. 2015;10:e0140295.
    PubMed     Text format     Abstract available


  301. ZHAO L, Xu J, Liang F, Li A, et al
    Effect of Chronic Psychological Stress on Liver Metastasis of Colon Cancer in Mice.
    PLoS One. 2015;10:e0139978.
    PubMed     Text format     Abstract available


  302. CHENG S, Wiklund P, Autio R, Borra R, et al
    Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0138889.
    PubMed     Text format     Abstract available


  303. MOTAWI TK, Shaker OG, El-Maraghy SA, Senousy MA, et al
    Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    PLoS One. 2015;10:e0137706.
    PubMed     Text format     Abstract available


  304. LIU F, Wang X, Wu G, Chen L, et al
    Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
    PLoS One. 2015;10:e0142457.
    PubMed     Text format     Abstract available


  305. ANDERSON EL, Howe LD, Jones HE, Higgins JP, et al
    The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0140908.
    PubMed     Text format     Abstract available


  306. FORNARI F, Ferracin M, Trere D, Milazzo M, et al
    Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
    PLoS One. 2015;10:e0141448.
    PubMed     Text format     Abstract available


  307. MISRA A, Anoop S, Gulati S, Mani K, et al
    Body Fat Patterning, Hepatic Fat and Pancreatic Volume of Non-Obese Asian Indians with Type 2 Diabetes in North India: A Case-Control Study.
    PLoS One. 2015;10:e0140447.
    PubMed     Text format     Abstract available


  308. LEE KS, Kwak Y, Nam KH, Kim DW, et al
    c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    PLoS One. 2015;10:e0139727.
    PubMed     Text format     Abstract available


  309. MA Y, Wang Q, Yang J, Yan L, et al
    Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    PLoS One. 2015;10:e0136604.
    PubMed     Text format     Abstract available


  310. DE OLIVEIRA PR, da Costa CA, de Bem GF, Cordeiro VS, et al
    Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
    PLoS One. 2015;10:e0143721.
    PubMed     Text format     Abstract available


  311. HUH JH, Ahn SV, Koh SB, Choi E, et al
    A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.
    PLoS One. 2015;10:e0143560.
    PubMed     Text format     Abstract available


  312. LI RK, Palmer SL, Zeng MS, Qiang JW, et al
    Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    PLoS One. 2015;10:e0142882.
    PubMed     Text format     Abstract available


  313. KUMAGAI K, Tabu K, Sasaki F, Takami Y, et al
    Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
    PLoS One. 2015;10:e0143413.
    PubMed     Text format     Abstract available


  314. BHATT SP, Misra A, Nigam P, Guleria R, et al
    Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.
    PLoS One. 2015;10:e0142260.
    PubMed     Text format     Abstract available


  315. HE YF, Wang CQ, Yu Y, Qian J, et al
    Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
    PLoS One. 2015;10:e0143657.
    PubMed     Text format     Abstract available


  316. WANG ZS, Guo WD, Wu LQ, Yi X, et al
    Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    PLoS One. 2015;10:e0142727.
    PubMed     Text format     Abstract available


  317. XU C, Qiao Z, Lu Y, Zhang D, et al
    Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis.
    PLoS One. 2015;10:e0142278.
    PubMed     Text format     Abstract available


  318. KARAJAMAKI AJ, Patsi OP, Savolainen M, Kesaniemi YA, et al
    Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
    PLoS One. 2015;10:e0142937.
    PubMed     Text format     Abstract available


  319. RENGA B, Cipriani S, Carino A, Simonetti M, et al
    Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
    PLoS One. 2015;10:e0141082.
    PubMed     Text format     Abstract available


  320. NISHIOJI K, Mochizuki N, Kobayashi M, Kamaguchi M, et al
    The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain >/=10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals.
    PLoS One. 2015;10:e0140427.
    PubMed     Text format     Abstract available


  321. BANERJEE A, Abdelmegeed MA, Jang S, Song BJ, et al
    Increased Sensitivity to Binge Alcohol-Induced Gut Leakiness and Inflammatory Liver Disease in HIV Transgenic Rats.
    PLoS One. 2015;10:e0140498.
    PubMed     Text format     Abstract available


  322. PETTA S, Marrone O, Torres D, Buttacavoli M, et al
    Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2015;10:e0142210.
    PubMed     Text format     Abstract available


  323. KARIMIAN G, Kirschbaum M, Veldhuis ZJ, Bomfati F, et al
    Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
    PLoS One. 2015;10:e0143121.
    PubMed     Text format     Abstract available


  324. VONGHIA L, Magrone T, Verrijken A, Michielsen P, et al
    Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features.
    PLoS One. 2015;10:e0143380.
    PubMed     Text format     Abstract available


  325. BERNSMEIER C, Weisskopf DM, Pflueger MO, Mosimann J, et al
    Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.
    PLoS One. 2015;10:e0143293.
    PubMed     Text format     Abstract available


  326. JIA G, Di F, Wang Q, Shao J, et al
    Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
    PLoS One. 2015;10:e0142808.
    PubMed     Text format     Abstract available


  327. GRANATA V, Fusco R, Catalano O, Filice S, et al
    Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.
    PLoS One. 2015;10:e0142876.
    PubMed     Text format     Abstract available


  328. BECKER PP, Rau M, Schmitt J, Malsch C, et al
    Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
    PLoS One. 2015;10:e0142661.
    PubMed     Text format     Abstract available


  329. JEON JY, Wang HJ, Ock SY, Xu W, et al
    Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation.
    PLoS One. 2015;10:e0143966.
    PubMed     Text format     Abstract available


    January 2014
  330. PLELI T, Martin D, Kronenberger B, Brunner F, et al
    Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis - a prospective cohort study.
    PLoS One. 2014;9:e103532.
    PubMed     Text format     Abstract available


  331. SAVERINO D, Pesce G, Antola P, Porcelli B, et al
    High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.
    PLoS One. 2014;9:e112509.
    PubMed     Text format     Abstract available


  332. NEGRIN KA, Roth Flach RJ, DiStefano MT, Matevossian A, et al
    IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis.
    PLoS One. 2014;9:e107265.
    PubMed     Text format     Abstract available


  333. LEE YH, Bang H, Park YM, Bae JC, et al
    Non-laboratory-based self-assessment screening score for non-alcoholic Fatty liver disease: development, validation and comparison with other scores.
    PLoS One. 2014;9:e107584.
    PubMed     Text format     Abstract available


  334. LIN WC, Chou KH, Chen CL, Chen HL, et al
    Longitudinal Brain White Matter Alterations in Minimal Hepatic Encephalopathy before and after Liver Transplantation.
    PLoS One. 2014;9:e105887.
    PubMed     Text format     Abstract available


  335. JANSEN C, Eischeid H, Goertzen J, Schierwagen R, et al
    The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS.
    PLoS One. 2014;9:e103779.
    PubMed     Text format     Abstract available


  336. LIU F, Jiao AX, Wu XR, Zhao W, et al
    Impact of glutathione s-transferase m1 and t1 on anti-tuberculosis drug-induced hepatotoxicity in chinese pediatric patients.
    PLoS One. 2014;9:e115410.
    PubMed     Text format     Abstract available


  337. GORCZYNSKI RM, Chen Z, Erin N, Khatri I, et al
    Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy.
    PLoS One. 2014;9:e113597.
    PubMed     Text format     Abstract available


  338. TAN Y, Pan T, Ye Y, Ge G, et al
    Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis.
    PLoS One. 2014;9:e111424.
    PubMed     Text format     Abstract available


  339. ZHU X, Zhang J, Fan W, Gong Y, et al
    MAPKAP1 rs10118570 Polymorphism Is Associated with Anti-Infection and Anti-Hepatic Fibrogenesis in Schistosomiasis Japonica.
    PLoS One. 2014;9:e105995.
    PubMed     Text format     Abstract available


  340. CHEN J, Xu X, Wu J, Ling Q, et al
    The stratifying value of hangzhou criteria in liver transplantation for hepatocellular carcinoma.
    PLoS One. 2014;9:e93128.
    PubMed     Text format     Abstract available


  341. ULAS A, Turkoz FP, Silay K, Tokluoglu S, et al
    A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2014;9:e114471.
    PubMed     Text format     Abstract available


  342. WANNHOFF A, Muller OJ, Friedrich K, Rupp C, et al
    Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    PLoS One. 2014;9:e112583.
    PubMed     Text format     Abstract available


  343. DVORAK K, Stritesky J, Petrtyl J, Vitek L, et al
    Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice - an exploratory case-control study.
    PLoS One. 2014;9:e111551.
    PubMed     Text format     Abstract available


  344. XIANG Z, Wang S, Xiang Y
    Up-Regulated MicroRNA499a by Hepatitis B Virus Induced Hepatocellular Carcinogenesis via Targeting MAPK6.
    PLoS One. 2014;9:e111410.
    PubMed     Text format     Abstract available


  345. BARDI DA, Halabi MF, Hassandarvish P, Rouhollahi E, et al
    Andrographis paniculata Leaf Extract Prevents Thioacetamide-Induced Liver Cirrhosis in Rats.
    PLoS One. 2014;9:e109424.
    PubMed     Text format     Abstract available


  346. KRAG A, Bendtsen F, Dahl EK, Kjaer A, et al
    Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study.
    PLoS One. 2014;9:e109179.
    PubMed     Text format     Abstract available


  347. KATO N, Sejima H, Ueda Y, Mori K, et al
    Genetic characterization of hepatitis C virus in long-term RNA replication using li23 cell culture systems.
    PLoS One. 2014;9:e91156.
    PubMed     Text format     Abstract available


  348. QI Z, Li L, Wang X, Gao X, et al
    Bone Marrow Transplantation Concurrently Reconstitutes Donor Liver and Immune System across Host Species Barrier in Mice.
    PLoS One. 2014;9:e106791.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: